Table 2 Cancer cases diagnosed in 2010, attributable to below-target exercise level in 2000

From: 9. Cancers attributable to inadequate physical exercise in the UK in 2010

Age (years)

Breast (post-menopausal)

Uterus (endometrium)

Colon

All cancers a

At exposure

At outcome (+10 years)

PAF

Observed cases

Excess attributable cases

PAF

Observed cases

Excess attributable cases

PAF

Observed cases

Excess attributable cases

Observed cases

Excess attributable cases

Men

 19–24

29–34

0.031

58

1.8

1333

1.8

 25–34

35–44

0.029

216

6.2

4124

6.2

 35–49

45–59

0.038

1451

55.5

22388

55.5

 50–64

60–74

0.046

5331

247.3

68043

247.3

 65–74

75–84

0.058

4339

250.6

44085

250.6

75

85

0.067

1598

106.9

16064

106.9

 Total (%)

 

 

13044

668.3 (5.1%)

158667

668.3 (0.4%)

Women

 19–24

29–34

0

582

0

0.032

28

0.9

0.043

60

2.5

2248

3.4

 25–34

35–44

0

3857

0

0.028

211

5.9

0.037

236

8.6

8619

14.5

 35–49

45–59

0.032

14 628

461.7

0.032

1926

60.8

0.042

1301

54.0

31 631

576.5

 50–64

60–74

0.035

17 194

602.8

0.035

3844

134.8

0.046

3914

180.3

54 966

917.9

 65–74

75–84

0.046

7584

352.4

0.046

1570

73.0

0.061

3873

235.9

35 386

661.2

75

85

0.054

4367

237.1

0.054

605

32.8

0.071

2299

163.3

20 050

433.3

 Total (%)

  

48 385

1654.1 (3.4%)

 

8195

308.1 (3.8%)

 

11 732

644.7 (5.5%)

155 584

2606.9 (1.7%)

Persons

 19–24

29–34

 

582

0

 

28

0.9

 

117

4.3

3582

5.2

 25–34

35–44

 

3857

0

 

211

5.9

 

452

14.8

12 743

20.7

 35–49

45–59

 

14 628

461.7

 

1926

60.8

 

2752

109.6

54 019

632.1

 50–64

60–74

 

17 194

602.8

 

3844

134.8

 

9245

427.6

123 009

1165.2

 65–74

75–84

 

7584

352.4

 

1570

73.0

 

8212

486.4

79 472

911.8

75

85

 

4367

237.1

 

605

32.8

 

3897

270.2

36 114

540.1

 Total (%)

  

48 385

1654.1 (3.4%)

 

8195

308.1 (3.8%)

 

24 776

1312.9 (5.3%)

314 251

3275.2 (1.0%)

  1. Abbreviations: PAF=population-attributable fraction.
  2. a Excluding non-melanoma skin cancer.